BG-75202
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BG-75202, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors [Phase 1]